Development of a gmp manufacturing process for nadph...

Cytotherapy 2020 / 05 Vol. 22; Iss. 5

Development of a gmp manufacturing process for nadph oxidase correction in mRNA transfected granulocytes and monocytes for patients with chronic granulomatous disease

Lei, H., Moses, L., Brault, J., Meis, R., Dahl, G., Malech, H., Deravin, S., Stroncek, D., Highfill, S.L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Cytotherapy
DOI:
10.1016/j.jcyt.2020.03.297
Date:
May, 2020
File:
PDF, 159 KB
2020
Conversion to is in progress
Conversion to is failed